LONDON--(BUSINESS WIRE)--Jul 11, 2019--
The global anti-thrombin III testing market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190711005036/en/
Technavio has released a new market research report on the global anti-thrombin III testing market from 2019-2023. (Graphic: Business Wire)
A key factor driving the growth of the global anti-thrombin III testing market size is the shift toward rapid diagnostics. Rapid diagnostics have gained immense popularity in recent years as they are quick and easy to perform and provide results with a faster turnaround time. They are suitable for emergency medical screening and can also be performed in medical facilities with limited resources. Moreover, the market is witnessing the development RDTs for the diagnosis of blood disorders. As all anti-thrombin III testing products support rapid diagnostics, their demand is likely to increase significantly in the coming years.
As per Technavio, the presence of various blood clotting disorders will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global anti-thrombin III testing market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
Global Anti-Thrombin III Testing Market: Presence of Various Blood Clotting Disorders
Anti-thrombin deficiency presents many symptoms that are very similar to other disorders, including protein S deficiency, protein C deficiency, and antiphospholipid syndrome. This allows medical practitioners to cross-check for these disorders by identifying anti-thrombin deficiency among patients. Thus, the presence of various blood clotting disorders is expected to fuel the growth of the anti-thrombin III testing market during the forecast period.
“The rising incidence of age-related medical conditions such as high blood pressure, and hypertension that can lead to CVDs is a major health concern which mandates early detection. These conditions can lead to the development of blood clots, which can be easily detected by using anti-thrombin tests. Thus, the rise in the geriatric population will fuel the anti-thrombin III testing market during the forecast period,” says a senior analyst at Technavio.
Global Anti-Thrombin III Testing Market: Segmentation Analysis
This market research report segments the global anti-thrombin III testing market by end-user (hospitals, laboratories, and academic and research institutions) and geographic regions (North America, Europe, Asia, and ROW).
The North American region led the anti-thrombin III testing market in 2018, followed by Europe, Asia, and ROW respectively. The growth of the anti-thrombin III testing market in North America can be attributed to several factors such as the rise in IVD tests, presence of a large number of vendors, and the growing demand for anti-thrombin III testing for blood disorders.
Looking for more information on this market?Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190711005036/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: OTHER HEALTH HEALTH HOSPITALS CARDIOLOGY
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 07/11/2019 07:00 AM/DISC: 07/11/2019 07:01 AM